Immunogen reported $831.1M in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US USD 285.8B 48.51B
Agios Pharmaceuticals AGIO:US USD 1.54B 7M
Amgen AMGN:US USD 140.14B 19.78B
Astellas Pharma 4503:JP JPY 3.63T 111.69B
AstraZeneca AZN:LN USD 173.83B 19.74B
Bluebird Bio BLUE:US USD 488M 192M
Bristol Myers Squibb BMY:US USD 152.98B 1.18B
Eli Lilly And LLY:US USD 347.61B 40.37B
Emergent Biosolutions EBS:US USD 589M 458M
Exelixis EXEL:US USD 5.17B 128M
Halozyme Therapeutics HALO:US USD 7.69B 2.25B
Heron Therapeutics HRTX:US USD 297M 204M
Immunogen IMGN:US USD 1.1B 40M
Intrexon XON:US USD 316M 125M
Karyopharm Therapeutics KPTI:US USD 385M 57M
Macrogenics MGNX:US USD 413M 200M
Nektar Therapeutics NKTR:US USD 425M 175M
Novartis NVS:US USD 217.36B 33.38B
Pfizer PFE:US USD 287.63B 42.03B
Regeneron Pharmaceuticals REGN:US USD 78.57B 3.48B
Roche Holding ROG:VX CHF 242.39B 20.72B
Sanofi SNY:US EUR 121.87B 24.49B
Seattle Genetics SGEN:US USD 23.86B 1.38B